Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib

por Kian, Waleed, Krayim, Bilal, Alsana, Hadel, Giles, Betsy, Purim, Ofer, Alguayn, Wafeek, Alguayn, Farouq, Peled, Nir, Roisman, Laila C.
Publicado 2023

An Unusual Presentation of HCC in a Patient with No Underlying Liver Disease: A Case Study

por Osyntsov, Anton, Zemel, Melanie, Cohen, Nir, Cooper, Jonah M., Krenawi, Muhammad, Krayim, Bilal, Kian, Waleed, Marei, Ranin, Shalata, Walid, Sebbag, Gilbert, Abu-Swis, Shadi
Publicado 2022

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer

por Kian, Waleed, Christopoulos, Petros, Remilah, Areen A., Levison, Esther, Dudnik, Elizabeth, Shalata, Walid, Krayim, Bilal, Marei, Ranin, Yakobson, Alexander, Faehling, Martin, Kahala, Dolev, Sara Granot, Inbal, Levitas, Dina, Peled, Nir, Roisman, Laila C.
Publicado 2022